網頁

星期二, 9月 26, 2023

麻州獲選為美國健康創新網的ARPA-H樞紐據點

Massachusetts Selected to Host ARPA-H Hub as Part of Nationwide Health Innovation Network  

State Lauded as Epicenter of Life Science and Health Care Innovation Globally in Federal Selection to Help Advance ARPA-H’s Mission to Accelerate Better Health 

Outcomes for Everyone 

 

BOSTON – Today, the federal Advanced Research Projects Agency for Health (ARPA-H), an agency within the National Institutes of Health, announced Massachusetts has been chosen to host its Investor Catalyst Hub to support ARPA-H’s mission by fostering collaboration among researchers, entrepreneurs, and investors to accelerate innovative ideas that transform health care.  

 

Massachusetts’ selection was announced during a press briefing with ARPA-H Director Dr. Renee Wegrzyn to formally launch ARPANET-H, a nationwide health innovation network comprised of three hubs across the country, each with an aim to accelerate better health outcomes for everyone. VentureWell, a nonprofit based in Hadley, Mass., with expertise in federal health care programs and complex program management, was selected as the organization that will run and manage the Massachusetts-based hub. The Investor Catalyst Hub will focus on helping ARPA-H programs navigate the complexities of the business and regulatory landscape and provide resources to help bring ideas to market. 

 

“This is a huge win for Massachusetts and an opportunity to bring economic development while strengthening our role as a nationwide leader in life sciences. We're excited to partner with ARPA-H and the Biden Administration to support the innovative ideas and breakthrough technologies that will revolutionize health care for all Americans," said Governor Maura Healey. "This hub leverages our state's world-class life science ecosystem while building a national network of researchers and entrepreneurs to invest in meaningful solutions to the biggest health care challenges. We thank the Biden Administration for making this critical funding available and our incredible federal delegation for their strong partnership throughout this process." 

 

"We are proud to be selected to host this hub as part of ARPA-H's national health innovation network,” said Lieutenant Governor Kim Driscoll. “Massachusetts is the global epicenter of life sciences innovation – we have the talent, expertise, and vision to make radical changes in medicine. We look forward to working with ARPA-H to nurture the ideas that will improve health care for patients everywhere.”  

 

"We have an unprecedented opportunity to spark revolutionary progress in health care and continue to lead in the life sciences industry through this partnership with ARPA-H," said Economic Development Secretary Yvonne Hao. "We are grateful to Team Massachusetts, including our partners across the public, private, and nonprofit sectors, the legislature, and the congressional delegation, for their support of our successful proposal to take part in this important effort to transform health care delivery." 

 

The hub will be located in Greater Boston and will be supported by “spokes” across the country comprised of partner organizations that will include hospitals, health centers, and research and academic institutions, all of which will work together to accelerate solutions to diseases like diabetes, Alzheimer’s, dementia, and other serious health challenges. The state’s selection to host the Investor Catalyst Hub demonstrates the federal government’s recognition of Massachusetts as a leading model for health care delivery and life sciences innovation that, through the hub and spoke model, can support the federal agency in its pursuit of moonshot projects to transform health care solutions for residents across the country. 

 

The Healey-Driscoll Administration, through the Executive Office of Economic Development (EOED) and the quasi-public agency Massachusetts Life Sciences Center, partnered with VentureWell and a consortium of industry leaders, hospitals, health centers, and research and academic institutions in pursuit of this opportunity. In March 2023, ARPA-H announced a multi-phase site selection process, which started with a proposal submission in April 2023.  
 

“Today is a victory for patients and for the collaborative spirit woven into our Commonwealth’s DNA,” said Massachusetts Life Sciences Center President and CEO Kenn Turner. “We are grateful for the opportunity to partner with ARPA-H and the Biden Administration on the next generation of medical breakthroughs that will transform lives on a global scale. I am so grateful for the support of the Healey-Driscoll Administration and the multitude of partners who helped us reach this milestone. An exciting chapter for our ecosystem begins now.” 

VentureWell has spent nearly three decades delivering on our mission - to solve the world’s biggest challenges and to create lasting impact through science and technology innovation and entrepreneurship and we see valuable opportunity in continuing to scale this work through our partnership with ARPA-H,” said Phil Weilerstein, President & CEO of VentureWell. “We bring the full set of organizational capabilities and experiences to accomplish ARPA-H’s goals and are honored to be given the opportunity to play a role in bringing life-changing medical and science breakthroughs out of the lab and into the hands of the people across the nation who need them.” 

 

VentureWell has extensive experience partnering with public and private institutions to bring solutions from the research lab and into the market through funding, training, mentorship, and network support, with a focus on health equity and inclusive innovation. As manager of the hub, VentureWell will design and manage the build-out of the hub and its spoke network, recruiting and engaging a nationwide network of diverse organizations representing financing and innovation, academic and clinical priorities, and care-setting transitions. The opportunity to apply to become a spoke is open to all institutions in the United States with strengths that align with the ARPA-H focus areas: health science futures, proactive health, scalable solutions, and resilient systems. 

  

In March 2022, President Biden announced the ARPA-H initiative to improve the U.S. government’s ability to speed biomedical and health research. Shortly after, Massachusetts formed the Coalition for Health Advancement and Research in Massachusetts (CHARM), composed of Massachusetts government, industry, and educational leaders, to initiate the state’s efforts to explore the opportunity. Under the Healey-Driscoll Administration, EOED tapped CHARM members to form a new coalition of public-private partners in March 2023 to pursue the Investor Catalyst Hub after the federal government outlined its competitive site selection process.  

 

The ARPA-H proposal is a part of the Healey-Driscoll Administration’s whole-of-government strategy to compete for federal money that has included applications for more than $2 billion dollars in federal funding to advance priorities for equity, competitiveness, workforce development and climate resiliency in Massachusetts. The approach has brought in tens of millions of dollars to the state in recent weeks, with additional funding still pending the decision of federal agencies. Last week, Massachusetts was awarded $19.7 million in funding through the federal CHIPS and Science Act to establish the Northeast Microelectronics Coalition Hub to advance the microelectronics needs of the U.S. Department of Defense while spurring new jobs, workforce training opportunities, and investment in the region’s advanced manufacturing and technology sectors. 

沒有留言: